新冠肺炎疫苗后脑静脉窦血栓形成

Pakistan Journal of Neurological Sciences Pub Date : 2022-12-03 DOI:10.56310/pjns.v17i02.185

Soban Khan, Mariam Khalil, Zaid Waqar

{"title":"新冠肺炎疫苗后脑静脉窦血栓形成","authors":"Soban Khan, Mariam Khalil, Zaid Waqar","doi":"10.56310/pjns.v17i02.185","DOIUrl":null,"url":null,"abstract":"Sinovac is an inactivated virus COVID 19 vaccine given emergency authorization for COVID 19 Pandemic. Different adverse reactions have been seen in after marketing of COVID 19 vaccines. Here we present a case of patient who developed cerebral venous sinus thrombosis two weeks after the first dose of SINOVAC vaccine.","PeriodicalId":19818,"journal":{"name":"Pakistan Journal of Neurological Sciences","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis\",\"authors\":\"Soban Khan, Mariam Khalil, Zaid Waqar\",\"doi\":\"10.56310/pjns.v17i02.185\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sinovac is an inactivated virus COVID 19 vaccine given emergency authorization for COVID 19 Pandemic. Different adverse reactions have been seen in after marketing of COVID 19 vaccines. Here we present a case of patient who developed cerebral venous sinus thrombosis two weeks after the first dose of SINOVAC vaccine.\",\"PeriodicalId\":19818,\"journal\":{\"name\":\"Pakistan Journal of Neurological Sciences\",\"volume\":\"35 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pakistan Journal of Neurological Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.56310/pjns.v17i02.185\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Journal of Neurological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56310/pjns.v17i02.185","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

科兴是一种COVID - 19灭活病毒疫苗，获得了COVID - 19大流行紧急授权。COVID - 19疫苗上市后出现了不同的不良反应。在此，我们报告一例患者在首次注射SINOVAC疫苗后两周发生脑静脉窦血栓形成。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis

Sinovac is an inactivated virus COVID 19 vaccine given emergency authorization for COVID 19 Pandemic. Different adverse reactions have been seen in after marketing of COVID 19 vaccines. Here we present a case of patient who developed cerebral venous sinus thrombosis two weeks after the first dose of SINOVAC vaccine.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pakistan Journal of Neurological Sciences

自引率

0.00%

发文量